Down-Regulation and Clinic-Pathological Correlation of SIK-1 and SIL-1-LNC in Non-Small Cell Lung Cancer Patients.

Alireza Anvarnia Reza Panahizadeh Habib Zarredar Milad Asadi Shahriyar Hashemzadeh Mohammad Amin Vatankhah Hamed Valizadeh Mortaza Raeisi

Published in: Asian Pacific journal of cancer prevention : APJCP (2023)

Collectively, our study emphasized the role of SIK-1-LNC and SIK-1 downregulation in NSCLC oncogenesis. Additionally, SIK-1 and SIK-1-LNC, particularly the latter, have shown remarkable potential to be utilized as new NSCLC biomarkers and therapeutic targets.

Keyphrases

small cell lung cancer
primary care
single cell
cell therapy
stem cells
signaling pathway
bone marrow
mesenchymal stem cells
climate change
tyrosine kinase